Emergency FDA authorization of remdesivir expected after experimental coronavirus drug shows promise in trial

dimitri karastelev g bydoibjq unsplash
Credit: Dimitri Karastelev on Unsplash

The F.D.A. plans to announce … an emergency use authorization for remdesivir, an experimental antiviral drug that is being tested in treating patients with Covid-19, the disease caused by the coronavirus, according to a senior administration official.

A federal trial has shown that treatment with remdesivir can speed recovery in patients infected with the coronavirus, Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, said on [April 29]. The drug, made by Gilead Sciences, could eventually become the first approved treatment for Covid-19, the illness caused by the coronavirus.

Earlier on Wednesday [April 29], Gilead had announced that the company was “aware of positive data” from the federal trial. Trading in the company’s stock was halted before the market opened, and the glimmer of good news drove stocks higher, despite poor economic data.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend